Your shopping cart is currently empty

KRAS G12C Peptide is a specific peptide derived from the Kirsten rat sarcoma virus (KRAS) gene that carries the G12C oncogenic mutation. This peptide induces responses such as IFN-γ secretion and cytotoxicity. KRAS G12C Peptide is utilized in studies investigating immune responses against tumors with the KRAS G12C mutation.
| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | KRAS G12C Peptide is a specific peptide derived from the Kirsten rat sarcoma virus (KRAS) gene that carries the G12C oncogenic mutation. This peptide induces responses such as IFN-γ secretion and cytotoxicity. KRAS G12C Peptide is utilized in studies investigating immune responses against tumors with the KRAS G12C mutation. |
| Molecular Weight | 888.1 |
| Formula | C38H69N11O11S |
| Cas No. | 1932689-40-1 |
| Smiles | [C@H](C(N[C@H](C(NCC(N[C@H](C(N[C@H](C(NCC(N[C@H](C(NCC(N[C@@H](CCCCN)C(O)=O)=O)=O)C(C)C)=O)=O)CS)=O)C)=O)=O)[C@H](C)C)=O)(NC([C@H](C(C)C)N)=O)C(C)C |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.